Shares of Indoco Remedies were trading 1% higher on Wednesday after the company received approval from the UK-MHRA (Medicines and Healthcare Products Regulatory Agency) for its new solid dosages manufacturing facility in Baddi, Himachal Pradesh (Baddi III unit).
The inspection was held from October 16 to 18, 2018, the company said in a press note today. The facility is spread over area of 18000sqm, with manufacturing capacity of 4.3bn tablets and 50 mn capsules per annum.
Indoco Remedies Ltd's share price is currently at Rs187.80, up by Rs2.1 or 1.13%, from its previous close of Rs185.70 on the BSE.
The scrip opened at Rs181.30 and has touched a high and low of Rs188 and Rs181.30, respectively. So far, 22,830 (NSE+BSE) shares have been traded on the counter. The current market cap of the company is Rs1,711.23cr.
|